These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
265 related articles for article (PubMed ID: 6797786)
1. Comparison of the metabolic effects of two hormonal contraceptive methods: an oral formulation and a vaginal ring. II. Serum lipoproteins and apolipoproteins. Ahrén T; Lithell H; Victor A; Vessby B; Johansson ED Contraception; 1981 Oct; 24(4):451-68. PubMed ID: 6797786 [TBL] [Abstract][Full Text] [Related]
2. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids. Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162 [TBL] [Abstract][Full Text] [Related]
3. Fasting plasma lipids, lipoproteins and apolipoproteins in Nigerian women using combined oral and progestin-only injectable contraceptives. Oyelola OO Contraception; 1993 May; 47(5):445-54. PubMed ID: 8513671 [TBL] [Abstract][Full Text] [Related]
4. Serum lipid and lipoprotein changes induced by new oral contraceptives containing ethinylestradiol plus levonorgestrel or desogestrel. Gaspard UJ; Buret J; Gillain D; Romus MA; Lambotte R Contraception; 1985 Apr; 31(4):395-408. PubMed ID: 3159546 [TBL] [Abstract][Full Text] [Related]
5. Effects of three low-dose oral contraceptive formulations on lipid metabolism. Bertolini S; Elicio N; Cordera R; Gapitanio GL; Montagna G; Croce S; Saturnino M; Balestreri R; De Cecco L Acta Obstet Gynecol Scand; 1987; 66(4):327-32. PubMed ID: 2962417 [TBL] [Abstract][Full Text] [Related]
6. Effect of two oral contraceptives containing ethinyl estradiol and gestodene or norgestimate on different lipid and lipoprotein parameters. Wiegratz I; Jung-Hoffmann C; Gross W; Kuhl H Contraception; 1998 Aug; 58(2):83-91. PubMed ID: 9773262 [TBL] [Abstract][Full Text] [Related]
7. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring. Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404 [TBL] [Abstract][Full Text] [Related]
8. The effect on lipids and lipoproteins of a contraceptive vaginal ring containing levonorgestrel and estradiol. Roy S; Krauss RM; Mishell DR; Casagrande J; Pike MC Contraception; 1981 Oct; 24(4):429-49. PubMed ID: 6797785 [TBL] [Abstract][Full Text] [Related]
9. A comparative study of the effects of a monophasic and a triphasic oral contraceptive containing ethinyl estradiol and levonorgestrel on lipid and lipoprotein metabolism. Loke DF; Ng CS; Samsioe G; Holck S; Ratnam SS Contraception; 1990 Nov; 42(5):535-54. PubMed ID: 2125546 [TBL] [Abstract][Full Text] [Related]
10. Oral contraceptive tablets containing 20 and 30 micrograms of ethinyl estradiol with 150 micrograms desogestrel. Their influence on lipids, lipoproteins, sex hormone binding globulin and testosterone. Akerlund M; Almström E; Högstedt S; Nabrink M Acta Obstet Gynecol Scand; 1994 Feb; 73(2):136-43. PubMed ID: 8116352 [TBL] [Abstract][Full Text] [Related]
11. A randomized comparative open study of the effects of two oral contraceptives, Triphasil and Ortho 7/7/7, on lipid metabolism. Kakis G; Powell M; Marshall A; Steiner G Contraception; 1993 Feb; 47(2):131-48. PubMed ID: 8449014 [TBL] [Abstract][Full Text] [Related]
12. Progestins and oral contraceptive-induced lipoprotein changes: a prospective study. Lipson A; Stoy DB; LaRosa JC; Muesing RA; Cleary PA; Miller VT; Gilbert PR; Stadel B Contraception; 1986 Aug; 34(2):121-34. PubMed ID: 3096633 [TBL] [Abstract][Full Text] [Related]
13. Plasma lipoproteins and fatty acid composition after "minipill". Sassolas A; Lagarde M; Guichardant M; Quincy C; Dechavanne M Contraception; 1983 Oct; 28(4):357-68. PubMed ID: 6421540 [TBL] [Abstract][Full Text] [Related]
14. Comparative metabolic effects of three types of combined oral contraceptive pills in Chinese women. Prasad RN; Liew D; Ratnam SS Contraception; 1989 Jan; 39(1):21-35. PubMed ID: 2521321 [TBL] [Abstract][Full Text] [Related]
15. A randomized crossover comparison of two low-dose contraceptives: effects on serum lipids and lipoproteins. März W; Gross W; Gahn G; Romberg G; Taubert HD; Kuhl H Am J Obstet Gynecol; 1985 Oct; 153(3):287-93. PubMed ID: 2931988 [TBL] [Abstract][Full Text] [Related]
16. A cross-over study of three oral contraceptives containing ethinyloestradiol and either desogestrel or levonorgestrel. Song S; Chen JK; Yang PJ; He ML; Li LM; Fan BC; Rekers H; Fotherby K Contraception; 1992 Jun; 45(6):523-32. PubMed ID: 1535580 [TBL] [Abstract][Full Text] [Related]
17. Comparison of the impact of vaginal and oral administration of combined hormonal contraceptives on hepatic proteins sensitive to estrogen. Sitruk-Ware RL; Menard J; Rad M; Burggraaf J; de Kam ML; Tokay BA; Sivin I; Kluft C Contraception; 2007 Jun; 75(6):430-7. PubMed ID: 17519148 [TBL] [Abstract][Full Text] [Related]
18. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism. Godsland IF; Crook D; Simpson R; Proudler T; Felton C; Lees B; Anyaoku V; Devenport M; Wynn V N Engl J Med; 1990 Nov; 323(20):1375-81. PubMed ID: 2146499 [TBL] [Abstract][Full Text] [Related]
19. A norgestimate-containing oral contraceptive: review of clinical studies. Kafrissen ME Am J Obstet Gynecol; 1992 Oct; 167(4 Pt 2):1196-202. PubMed ID: 1415446 [TBL] [Abstract][Full Text] [Related]
20. Lipoprotein patterns in women in Santo Domingo using a levonorgestrel/estradiol contraceptive ring. Robertson DN; Alvarez F; Sivin I; Brache V; Stern J; Leon P; Faundes A Contraception; 1981 Oct; 24(4):469-80. PubMed ID: 6797787 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]